Potential role of nuclear factor κB in diabetic cardiomyopathy

Area of Science:

• Cardiology
• Molecular Biology
• Endocrinology

Background:

• Diabetic cardiomyopathy (DCM) is heart injury from diabetes, separate from vascular disease or hypertension.
• Transcription factors regulate gene expression in disease development.
• Nuclear Factor-kappa B (NF-κB) is a key transcription factor implicated in various heart diseases.

Purpose of the Study:

• To review the Nuclear Factor-kappa B (NF-κB) pathway.
• To investigate the role of NF-κB in processes linked to diabetic cardiomyopathy.

Main Methods:

• Literature review of scientific papers and studies.
• Analysis of the NF-κB signaling pathway.
• Examination of NF-κB's involvement in oxidative stress, inflammation, endothelial dysfunction, fibrosis, hypertrophy, and apoptosis.

Main Results:

• NF-κB is a critical transcription factor in cardiovascular regulation.
• Evidence suggests NF-κB activation contributes to DCM pathogenesis.
• NF-κB influences multiple cellular processes implicated in diabetic heart injury.

Conclusions:

• NF-κB plays a significant role in diabetic cardiomyopathy.
• Targeting the NF-κB pathway may offer therapeutic strategies for DCM.
• Further research is needed to fully elucidate NF-κB's complex role in diabetic heart disease.